In nearly two-thirds of U.S. states, cancer patients weren’t put at the front of the line for COVID-19 vaccines in the initial phase of vaccination, a new study finds. Many cancer patients are especially vulnerable to COVID-19 as the disease or related treatments leaves them with weakened immune systems. Perhaps many cancer patients were skipped… read on > read on >







